Bristol Gate Capital Partners Inc.
45 St Clair Avenue West Suite 601
Toronto, Ontario M4V 1K9
  • Our Research in Action: CVS Health

  • Our Research in Action: CVS Health

  • Our Research in Action: CVS Health

  • Our Research in Action: CVS Health

  • Our Research in Action: CVS Health

  • Our Research in Action: CVS Health

CVS Health was purchased by Bristol Gate’s US Equity Fund at inception, in May 2009. It has been held in the portfolio ever since. The company has undergone substantial expansion and is now one of the nation’s largest pharmacy benefits managers as well as an operator of a national retail store chain.

The table below summarizes the company’s financial results and growth rates since 2010. Asset growth has been 4% during this period and debt has increased at a compound rate of 7%. Strong growth in cash flow from operations has been deployed to acquire and reinvest, to reduce the share count and to grow the dividend at an exceptional rate during this period. In 2015, the dividend paid was $1.40, an increase of 27% over 2014. The 2016 dividend has been increased a further 21%. We believe the company will have the resources to meet our dividend growth requirements again in 2017.

(in Millions) 2010 2011 2012 2013 2014 Growth
Revenue 95,700 107,080 123,120 126,761 139,367 9%
Operating Profit 6, 133 6,331 7,210 8,037 8,799 9%
Cash Flow from Ops 4,779 5,856 6,671 5,783 8,137 14%
Dividend 0.35 0.50 0.65 0.90 1.10 35%
EPS 2.49 2.57 3.02 3.74 3.96 12%
Dividend 1,363 1,298 1,231 1,180 1,140 (4%)